Serum prostate specific antigen as pre-screening test for prostate cancer.
about
Prostate-specific antigen testing accuracy in community practice.Toward a better understanding of the comparatively high prostate cancer incidence rates in UtahThe development of a web- and a print-based decision aid for prostate cancer screening.SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerNovel diagnostic biomarkers for prostate cancer.Prostate-specific antigen in the early detection of prostate cancer.Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy.Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in FinlandDoes screening for prostate cancer identify clinically important disease?Accuracy of a high prostate-specific antigen level for prostate cancer diagnosis upon initial biopsy in Korean men.Usefulness of Total PSA Value in Prostate Diseases Diagnosis.PSA screening for prostate cancer: why so much controversy?Biomarkers for prostate cancer: present challenges and future opportunities.Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.Ten-core versus 16-core transrectal ultrasonography guided prostate biopsy for detection of prostatic carcinoma: a prospective comparative study in Indian population.Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men.Screening for prostate cancer today.Overexpression of TFF3 is involved in prostate carcinogenesis via blocking mitochondria-mediated apoptosis
P2860
Q24799377-BAF19B12-B3B4-44DB-8045-01FE2922C669Q24800113-38C799C7-79EE-4D5C-B824-8418206BA076Q30493869-7B3C7DB1-C598-4A3A-9B6E-83DADD20B53AQ33306300-03EBE189-C8F0-4C88-8FE2-53C8140CE4A9Q34231678-8D04A049-07BA-4EB5-876E-98B58BA43206Q35840271-FBCD994B-1D26-494E-B6C9-09599800178EQ35977609-2D436A03-273F-44DE-B064-134915A0DD69Q36135888-6BCEE685-B536-4410-9F55-80C95AB21C2CQ36822054-2691A458-17AC-49B6-BF01-388FA966F16AQ37065290-FBDA726B-7C29-440C-808B-421E45D70BDAQ37104224-F29F9FB2-EF65-4297-A2C5-C4EA736C1AEBQ37436987-9BB07714-EA6B-49C6-8846-D3EBE2B587BEQ37474443-B3E27731-9989-4110-A127-337C6B8628E7Q39781202-43FF37D3-B8DD-45A2-9EC0-90F6295788C4Q40162083-6A3533C9-8E4A-4BDC-8CBC-F4B9610CB9DDQ40755618-51D4064A-44B9-4DAD-AAE2-E203A7D6CDB8Q42113376-E6789F4A-B98F-4DD4-90B5-F546478F4569Q58714770-B8F4DEF8-21B5-430D-99C5-C0EC8086C143
P2860
Serum prostate specific antigen as pre-screening test for prostate cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Serum prostate specific antigen as pre-screening test for prostate cancer.
@en
Serum prostate specific antigen as pre-screening test for prostate cancer.
@nl
type
label
Serum prostate specific antigen as pre-screening test for prostate cancer.
@en
Serum prostate specific antigen as pre-screening test for prostate cancer.
@nl
prefLabel
Serum prostate specific antigen as pre-screening test for prostate cancer.
@en
Serum prostate specific antigen as pre-screening test for prostate cancer.
@nl
P2093
P1476
Serum prostate specific antigen as pre-screening test for prostate cancer.
@en
P2093
M Tremblay
P304
846-51; discussion 851-2
P407
P433
P577
1992-03-01T00:00:00Z